Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Control of nuclear receptor activities in metabolism by post-translational modifications.

Berrabah W, Aumercier P, Lefebvre P, Staels B.

FEBS Lett. 2011 Jun 6;585(11):1640-50. doi: 10.1016/j.febslet.2011.03.066. Epub 2011 Apr 7. Review.

2.

Molecular basis for the regulation of the nuclear receptor LRH-1.

Stein S, Schoonjans K.

Curr Opin Cell Biol. 2015 Apr;33:26-34. doi: 10.1016/j.ceb.2014.10.007. Epub 2014 Nov 15. Review.

PMID:
25463843
3.

Phosphorylation control of nuclear receptors.

Lalevée S, Ferry C, Rochette-Egly C.

Methods Mol Biol. 2010;647:251-66. doi: 10.1007/978-1-60761-738-9_15. Review.

PMID:
20694672
4.

Structure-activity relationship of nuclear receptor-ligand interactions.

Greschik H, Moras D.

Curr Top Med Chem. 2003;3(14):1573-99. Review.

PMID:
14683516
5.

Emerging roles of the ubiquitin proteasome system in nuclear hormone receptor signaling.

Lonard DM, O'Malley BW.

Prog Mol Biol Transl Sci. 2009;87:117-35. doi: 10.1016/S1877-1173(09)87004-X. Epub 2009 Oct 7. Review.

PMID:
20374703
6.

Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation.

Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C.

J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):267-73. Review.

PMID:
12943712
7.

Controlling nuclear receptors: the circular logic of cofactor cycles.

Perissi V, Rosenfeld MG.

Nat Rev Mol Cell Biol. 2005 Jul;6(7):542-54. Review.

PMID:
15957004
8.

[Post-translational modifications modulate estrogen receptor alpha activity in breast tumors].

Poulard C, Bouchekioua-Bouzaghou K, Sentis S, Corbo L, Le Romancer M.

Med Sci (Paris). 2010 Jun-Jul;26(6-7):636-40. doi: 10.1051/medsci/2010266-7636. Review. French.

9.

Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications.

Kishimoto M, Fujiki R, Takezawa S, Sasaki Y, Nakamura T, Yamaoka K, Kitagawa H, Kato S.

Endocr J. 2006 Apr;53(2):157-72. Review.

10.

Orphan nuclear receptors: therapeutic opportunities in skeletal muscle.

Smith AG, Muscat GE.

Am J Physiol Cell Physiol. 2006 Aug;291(2):C203-17. Review.

11.

Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation.

Treuter E, Venteclef N.

Biochim Biophys Acta. 2011 Aug;1812(8):909-18. doi: 10.1016/j.bbadis.2010.12.008. Epub 2010 Dec 21. Review.

12.

Post-translational modifications of steroid receptors.

Faus H, Haendler B.

Biomed Pharmacother. 2006 Nov;60(9):520-8. Epub 2006 Aug 28. Review.

PMID:
16949786
13.
14.

Multi-modulation of nuclear receptor coactivators through posttranslational modifications.

Han SJ, Lonard DM, O'Malley BW.

Trends Endocrinol Metab. 2009 Jan;20(1):8-15. doi: 10.1016/j.tem.2008.10.001. Epub 2008 Nov 18. Review.

15.

Diversity and function of orphan nuclear receptors in nematodes.

Van Gilst M, Gissendanner CR, Sluder AE.

Crit Rev Eukaryot Gene Expr. 2002;12(1):65-88. Review.

PMID:
12433066
16.

Posttranslational Modifications of Lipid-Activated Nuclear Receptors: Focus on Metabolism.

Becares N, Gage MC, Pineda-Torra I.

Endocrinology. 2017 Feb 1;158(2):213-225. doi: 10.1210/en.2016-1577. Review.

PMID:
27925773
17.

Post-translational modifications of nuclear co-repressor RIP140: a therapeutic target for metabolic diseases.

Mostaqul Huq MD, Gupta P, Wei LN.

Curr Med Chem. 2008;15(4):386-92. Review.

PMID:
18288993
18.

New developments in post-translational modifications and functions of histone H2A variants.

Thambirajah AA, Li A, Ishibashi T, Ausió J.

Biochem Cell Biol. 2009 Feb;87(1):7-17. doi: 10.1139/O08-103. Review.

PMID:
19234519
19.

Beyond CAR and PXR.

Dixit SG, Tirona RG, Kim RB.

Curr Drug Metab. 2005 Aug;6(4):385-97. Review.

PMID:
16101576
20.

Ubiquitin-like protein modifications in prostate and breast cancer.

Wu F, Mo YY.

Front Biosci. 2007 Jan 1;12:700-11. Review.

PMID:
17127330

Supplemental Content

Support Center